No Detail Found!

Effect of budesonide combined with vitamin C on the inflammation response of pediatric mycoplasma pneumoniae pneumonia

Author(s)
Yinfang Li Department of Pediatrics, Nanjing First Hospital, Nanjing Medical University,Nanjing, Jiangsu,China
Xia Kong Department of Pediatrics, Nanjing First Hospital, Nanjing Medical University,Nanjing, Jiangsu,China
Dan Xu Department of Pediatrics, Nanjing First Hospital, Nanjing Medical University,Nanjing, Jiangsu,China
Peiling Yin Department of Pediatrics, Nanjing First Hospital, Nanjing Medical University,Nanjing, Jiangsu,China
Abstract
To observe the therapeutic effect of vitamin C combined with budesonide (BUD) on Mycoplasma pneumoniae (MP) pneumonia. A total of 106 children with MP admitted to our hospital from June 2021 to December 2024 were selected for the study. 57 children received vitamin C combined with conventional treatment (control group); the other 49 children were treated with vitamin C combined with BUD treatment (research group). The clinical efficacy of the two groups was compared and the time of disappearance of fever, cough and pulmonary wet rales was counted. Lung function, inflammatory factor and immunoglobulin levels were measured before and after treatment and adverse reactions were recorded. The results showed that the total effective rate of treatment in the study group was higher than that in the control group, while the time of fever, cough and disappearance of pulmonary wet rales was shorter than that in the control group (P0.05). These results suggest that the combination of vitamin C and budesonide may be of great value in the future treatment of MP pneumonia.
Publication Details
Page(s) 789-794
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Vitamin C, Immunoglobulin, Mycoplasma pneumoniae pneumonia, Budesonide
References
Agusti A,De Stefano G,Levi A,Munoz X,RomeroMesones C,Sibila O,Lopez-Giraldo A,Plaza Moral V,Curto E,Echazarreta AL,Marquez SE,Pascual-Guardia S,Santos S,Marin A,Valdes L,Saldarini F,Salgado C,Casanovas G,Varea S,Rios J,Faner R .2022 .Addon inhaled budesonide in the treatment of hospitalised patients with COVID-19: A randomised clinical trial. Eur. Respir. J., 59(3) : 2103036.
Boonyaratanakornkit J,Englund JA,Magaret AS,Bu Y,Tielsch JM,Khatry SK,Katz J,Kuypers J,Shrestha L,LeClerq SC,Steinhoff MC,Chu HY MC .2020 .Primary and repeated respiratory viral infections among infants in rural nepal. J. Pediatric. Infect. Dis. Soc., 9(1) : 21-29.
Chen J,Zhu Y,Zheng C,Zhao W,Liu Q .2023 .Clinical efficacy of budesonide combined with acetylcysteine in the treatment of mycoplasma pneumonia infection. Immun. Inflamm. Dis., 11(11) : e1068.
Daval M,Corre A,Palpacuer C,Housset J,Poillon G,Eliezer M,Verillaud B,Slama D,Ayache D,Herman P,Jourdaine C,Herve C,El Bakkouri W,Salmon D,Hautefort C .2020 .Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial. Trials., 21(1) : 666.
De Groot RCA,Zhu H,Hoogenboezem T,de Bruijn A,Eenjes E,t Jong AEJ,Belo AI,Estevao SC,Bajramovic JJ,Rottier RJ,Kool M,van Rossum AMC,Unger WWJ .2022 .Mycoplasma pneumoniae Compared to Streptococcus pneumoniae avoids induction of Proinflammatory Epithelial cell responses despite robustly inducing TLR2 Signaling. , 90(8) : e0012922.
Erciyestepe SG,Pata O .2024 .COVID-19 positive woman presented with major fetal congenital anomalies: A case report with literature review. Medicine (Baltimore), 103(36) : e39504.
Gordon DS,Rudinsky AJ,Guillaumin J,Parker VJ,Creighton KJ .2020 .Vitamin C in health and disease: A companion animal focus. Top Companion Anim. Med, 39 : 100432.
Gruber-Bzura BM .2022 .High-dose Vitamin C supplementation as a legitimate anti-SARS-CoV-2 prophylaxis in healthy subjects-yes or no? Nutrients. , 14(5) : 979.
Ha EK,Jin JO,Kim JH,Shin J,Lee GC,Cha HR,Choi SH,Han MY .2024 .Age-related effects of Mycoplasma pneumoniae infection and subsequent asthma exacerbation in children. , 59(6) : 1569-1577.
Li Y,Yang W,Wu X,Gou X .2022 .Effect of bronchofiberscopic lavage with budesonide suspension on refractory mycoplasma pneumoniae pneumonia. Pak. J. Med. Sci., 38 : 922-927.
Meyer Sauteur PM,Panisova E,Seiler M,Theiler M,Berger C,Dumke R C .2021 .Mycoplasma pneumoniae genotypes and clinical outcome in children. J. Clin. Microbiol, 59(7) : e0074821.
Meyer Sauteur PM,Truck J,van Rossum AMC,Berger C .2020 .Circulating antibody-secreting cell response during mycoplasma pneumoniae childhood pneumonia. J. Infect. Dis., 222(1) : 136-147.
Pei H,Ma Y,Wang L,Wang L,Xu L,Wang R .2021 .Effects of Shenfu injection on inflammatory factors and immune function in children with Mycoplasma pneumoniae: A protocol for a double-blind, randomized controlled trial. Medicine (Baltimore), 100(42) : e27585.
Peng Y,Chen Z,Li Y,Lu Q,Li H,Han Y,Sun D,Li X .2022 .Combined therapy of Xiaoer Feire Kechuan oral liquid and azithromycin for mycoplasma Pneumoniae pneumonia in children: A systematic review & metaanalysis. , 96 : 153899.
Periasamy N,Pujary K,Bhandarkar AM,Bhandarkar ND,Ramaswamy B .2020 .Budesonide vs saline nasal irrigation in allergic rhinitis: A randomized placebocontrolled trial. Otolaryngol, 162(6) : 979-984.
Tsai TA,Tsai CK,Kuo KC,Yu HR .2021 .Rational stepwise approach for mycoplasma pneumoniae pneumonia in children. J. Microbiol Immunol Infect., 54(4) : 557-565.
Tsao PC,Lin CH,Lee YS,Chen WY,Jeng MJ,Kou YR .2021 .Efficacy of intratracheal budesonide-surfactant combined therapy in surfactant-insufficient rat lungs with lipopolysaccharide insult. J. Chin. Med, 84(8) : 783-790.
Xu F,Zhang Q,Chen F Q .2024 .Effect of electronic fibrobronchoscope alveolar lavage combined with local administration of budesonide on the efficacy of Mycoplasma pneumoniae pneumonia in children. Allergol Immunopathol (Madr). , 52(6) : 51-57.
Xu Y,Yang C,Sun P,Zeng F,Wang Q,Wu J,Fang C,Zhang C,Wang J,Gu Y,Wu X,Zhang X,Yang B,Yang J,Zhang H,Lian J,Zhang J,Huang L,Lian Q .2024 .Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: A 6-year study in southern China. Emerg. Microbes. Infect., 13(1) : 2353298.
Zhu Y,Luo Y,Li L,Jiang X,Du Y,Wang J,Li H,Gu H,Li D,Tang H,Qin H,Xu C,Liu Y,Zhao D,Guo Y,Liu F Y .2023 .Immune response plays a role in Mycoplasma pneumoniae pneumonia. Front Immunol, 14 : 1189647.
0

Citations

0

Downloads

174

Views